These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11261803)

  • 1. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
    Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
    Acta Neurol Scand Suppl; 2000; 176():34-41. PubMed ID: 11261803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.
    Rei RT; Sabbagh MN; Corey-Bloom J; Tiraboschi P; Thal LJ
    Neurobiol Aging; 2000; 21(5):741-6. PubMed ID: 11016544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
    Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
    Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
    Martin-Ruiz CM; Court JA; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry RH; Perry EK
    J Neurochem; 1999 Oct; 73(4):1635-40. PubMed ID: 10501210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
    Perry E; Martin-Ruiz C; Lee M; Griffiths M; Johnson M; Piggott M; Haroutunian V; Buxbaum JD; Nãsland J; Davis K; Gotti C; Clementi F; Tzartos S; Cohen O; Soreq H; Jaros E; Perry R; Ballard C; McKeith I; Court J
    Eur J Pharmacol; 2000 Mar; 393(1-3):215-22. PubMed ID: 10771016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
    Teaktong T; Graham A; Court J; Perry R; Jaros E; Johnson M; Hall R; Perry E
    Glia; 2003 Jan; 41(2):207-11. PubMed ID: 12509811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.
    Court JA; Ballard CG; Piggott MA; Johnson M; O'Brien JT; Holmes C; Cairns N; Lantos P; Perry RH; Jaros E; Perry EK
    Pharmacol Biochem Behav; 2001 Dec; 70(4):571-9. PubMed ID: 11796155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic receptor subtypes in human brain related to aging and dementia.
    Perry EK; Martin-Ruiz CM; Court JA
    Alcohol; 2001 Jun; 24(2):63-8. PubMed ID: 11522424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex.
    Ballard CG; Court JA; Piggott M; Johnson M; O'Brien J; McKeith I; Holmes C; Lantos P; Jaros E; Perry R; Perry E
    Conscious Cogn; 2002 Sep; 11(3):461-74. PubMed ID: 12435378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
    Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
    Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies.
    Sabbagh MN; Reid RT; Hansen LA; Alford M; Thal LJ
    J Neural Transm (Vienna); 2001; 108(10):1149-57. PubMed ID: 11725817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic receptor abnormalities in the cerebellar cortex in autism.
    Lee M; Martin-Ruiz C; Graham A; Court J; Jaros E; Perry R; Iversen P; Bauman M; Perry E
    Brain; 2002 Jul; 125(Pt 7):1483-95. PubMed ID: 12076999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease.
    Chan PC; Wei CY; Hung GU; Chiu PY
    Brain Behav; 2018 Mar; 8(3):e00916. PubMed ID: 29541536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.